MARGARET RILEY: Open Payments
NPI 1134284656 · ROXBURY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,568 in 45 payments from 7 companies in 2025. Trend: 2023 $370 · 2024 $1,136 · 2025 $1,568
Food & beverage: $1,457Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $501 |
| Teva Pharmaceuticals USA, Inc. | 14 | $394 |
| Neurocrine BioSciences, Inc. | 9 | $303 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $185 |
| Vanda Pharmaceuticals Inc. | 3 | $102 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| Lundbeck LLC | 1 | $16 |
Products named: COBENFY, INGREZZA, CAPLYTA, AUSTEDO XR, UZEDY, FANAPT, INVEGA SUSTENNA, REXULTI.
Industry payments across MA — which companies pay providers there.
